720
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Venous Thromboembolism in Pregnancy: Challenges and Solutions

, , , & ORCID Icon
Pages 469-484 | Received 02 Jun 2023, Accepted 13 Jul 2023, Published online: 20 Jul 2023

References

  • Morris JM, Algert CS, Roberts CL. Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost. 2010;8(5):998–1003. doi:10.1111/j.1538-7836.2010.03794.x
  • Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet. 2010;375(9713):500–512. doi:10.1016/S0140-6736(09)60996-X
  • Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ. 2003;52(2):1–8.
  • Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108(1):56–60. doi:10.1111/j.1471-0528.2001.00004.x
  • Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706. doi:10.7326/0003-4819-143-10-200511150-00006
  • Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258–1265. doi:10.1016/S0140-6736(98)10265-9
  • McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy-associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183–1188.
  • Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132(1):4–10. doi:10.1016/j.ijgo.2015.06.054
  • Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632–637. doi:10.1111/j.1538-7836.2008.02921.x
  • Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–3359. doi:10.1182/bloodadvances.2018024802
  • Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost. 2002;87(5):791–795.
  • Ginsberg JS, Brill-Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost. 1992;67(5):519–520.
  • James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315. doi:10.1016/j.ajog.2005.11.008
  • James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193(1):216–219. doi:10.1016/j.ajog.2004.11.037
  • Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e691S–e736S. doi:10.1378/chest.11-2300
  • Blondon M, Harrington LB, Righini M, Boehlen F, Bounameaux H, Smith NL. Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study. J Thromb Haemost. 2014;12(12):2002–2009. doi:10.1111/jth.12747
  • Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–168. doi:10.1016/s1521-6926(03)00021-5
  • Dalaker K, Prydz H. The coagulation factor VII in pregnancy. Br J Haematol. 1984;56(2):233–241. doi:10.1111/j.1365-2141.1984.tb03951.x
  • Thornton P, Douglas J. Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2010;24(3):339–352. doi:10.1016/j.bpobgyn.2009.11.010
  • Estellés A, Gilabert J, Andrés C, España F, Aznar J. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy. Thromb Haemost. 1990;64(2):281–285.
  • Sheu JR, Hsiao G, Lin WY, et al. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy. J Biomed Sci. 2002;9(1):17–25. doi:10.1007/BF02256574
  • Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci. 1994;86(6):731–739. doi:10.1042/cs0860731
  • Aharon A, Katzenell S, Tamari T, Brenner B. Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost. 2009;7(6):1047–1050. doi:10.1111/j.1538-7836.2009.03342.x
  • Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27(2):89–94. doi:10.5830/CVJA-2016-021
  • Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003–1008. doi:10.1161/CIRCULATIONAHA.114.009029
  • Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104(2):191–197. doi:10.1111/j.1471-0528.1997.tb11043.x
  • James AH. Pregnancy-associated thrombosis. Hematology. 2009;2009(1):277–285. doi:10.1182/asheducation-2009.1.277
  • Carr MH, Towers CV, Eastenson AR, Pircon RA, Iriye BK, Adashek JA. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? J Matern Fetal Med. 1997;6(5):264–267. doi:10.1002/(SICI)1520-6661(199709/10)6:5<264::AID-MFM4>3.0.CO;2-E
  • Kovacevich GJ, Gaich SA, Lavin JP, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;182(5):1089–1092. doi:10.1067/mob.2000.105405
  • Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40–51. doi:10.1016/j.thromres.2020.05.008
  • Daikoku T, Matsumoto H, Gupta RA, et al. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem. 2003;278(9):7683–7691. doi:10.1074/jbc.M211390200
  • Song G, Kim J, Bazer FW, Spencer TE. Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus. Endocrinology. 2008;149(4):1926–1934. doi:10.1210/en.2007-1530
  • Chen J, Khalil RA. Matrix metalloproteinases in normal pregnancy and preeclampsia. Prog Mol Biol Transl Sci. 2017;148:87–165. doi:10.1016/bs.pmbts.2017.04.001
  • James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326–331. doi:10.1161/ATVBAHA.109.184127
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 197: inherited Thrombophilias in Pregnancy. Obstet Gynecol. 2018;132(1):e18–e34. doi:10.1097/AOG.0000000000002703
  • Ridker PM. Ethnic distribution of factor V Leiden in 4047 men and women. JAMA. 1997;277(16):1305. doi:10.1001/jama.1997.03540400055031
  • Nikolaeva MG, Momot AP, Zainulina MS, Yasafova NN, Taranenko IA. Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity. Thromb J. 2021;19(1):41. doi:10.1186/s12959-021-00289-4
  • Mekaj Y, Lulaj S, Daci F, et al. Prevalence and role of Antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy. J Hum Reprod Sci. 2015;8(4):224. doi:10.4103/0974-1208.170407
  • Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, Protein C, or Protein S deficiency. Arterioscler Thromb Vasc Biol. 1996;16(6):742–748. doi:10.1161/01.ATV.16.6.742
  • Makris M. Thrombophilia: grading the risk. Blood. 2009;113(21):5038–5039. doi:10.1182/blood-2009-02-203281
  • Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol. 2003;16(2):243–259. doi:10.1016/s1521-6926(03)00022-7
  • Pabinger I, Grafenhofer H, Kaider A, et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005;3(5):949–954. doi:10.1111/j.1538-7836.2005.01307.x
  • Khare M, Nelson-Piercy C. Acquired thrombophilias and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17(3):491–507. doi:10.1016/S1521-6934(03)00013-0
  • Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. Pathophysiol Haemost Thromb. 1985;15(4):254–262. doi:10.1159/000215157
  • Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJW. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985;19(3):265–275. doi:10.1002/ajh.2830190308
  • Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332(15):993–997. doi:10.1056/NEJM199504133321504
  • Branch DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin Perinatol. 1990;14(2):139–146.
  • Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 1996;14(2):131–136.
  • Ringrose DK. Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients. Int J Obstet Anesth. 1997;6(2):107–111. doi:10.1016/S0959-289X(97)80007-6
  • Bates SM. Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology. 2007;2007(1):143–150. doi:10.1182/asheducation-2007.1.143
  • Chan WS, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ. 2010;182(7):657–660. doi:10.1503/cmaj.091692
  • Hull RD, Raskob GE, Carter CJ. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings. Ann Intern Med. 1990;112(9):663–667. doi:10.7326/0003-4819-112-9-663
  • RCOG. Thromboembolic disease in pregnancy and the puerperium: acute management; green-top guideline No. 37b; 2001.
  • Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527–553. doi:10.1016/s1701-2163(15)30569-7
  • Dronkers CEA, Srámek A, Huisman MV, Klok FA. Accurate diagnosis of iliac vein thrombosis in pregnancy with magnetic resonance direct thrombus imaging (MRDTI). BMJ Case Rep. 2016;2016. doi:10.1136/bcr-2016-218091
  • Torkzad MR, Bremme K, Hellgren M, et al. Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy. Thromb Res. 2010;126(2):107–112. doi:10.1016/j.thromres.2010.05.011
  • Damodaram M, Kaladindi M, Luckit J, Yoong W. D-dimers as a screening test for venous thromboembolism in pregnancy: is it of any use? J Obstet Gynaecol. 2009;29(2):101–103. doi:10.1080/01443610802649045
  • Levy MS, Spencer F, Ginsberg JS, Anderson JAM. Reading between the (guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy. Thromb Res. 2008;121(5):705–707. doi:10.1016/j.thromres.2007.07.001
  • To MS, Hunt BJ, Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy. J Obstet Gynaecol. 2008;28(2):222–223. doi:10.1080/01443610801915975
  • Gibson PS, Powrie R. Anticoagulants and pregnancy: when are they safe? Cleve Clin J Med. 2009;76(2):113–127. doi:10.3949/ccjm.75a.072272
  • Krivak TC, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol. 2007;109(3):761–777. doi:10.1097/01.AOG.0000255819.10187.70
  • Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401–407. doi:10.1182/blood-2005-02-0626
  • Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007;146(3):211–222. doi:10.7326/0003-4819-146-3-200702060-00150
  • van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004;CD001100. doi:10.1002/14651858.CD001100.pub2
  • Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol. 2001;52(6):708–710. doi:10.1046/j.0306-5251.2001.01517.x
  • Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):627S–644S. doi:10.1378/chest.126.3_suppl.627S
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 196: thromboembolism in pregnancy. Obstet Gynecol. 2011;118(3):718–729. doi:10.1097/AOG.0b013e3182310c4c
  • Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):401S–428S. doi:10.1378/chest.126.3_suppl.401S
  • Schulman S, Granqvist S, Holmström M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The duration of anticoagulation trial study group. N Engl J Med. 1997;336(6):393–398. doi:10.1056/NEJM199702063360601
  • Bagaria SJ, Bagaria VB. Strategies for diagnosis and prevention of venous thromboembolism during pregnancy. J Pregnancy. 2011;2011:206858. doi:10.1155/2011/206858
  • Middleton P, Shepherd E, Gomersall JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2021;3(3):CD001689. doi:10.1002/14651858.CD001689.pub4
  • Harris SA, Velineni R, Davies AH. Inferior vena cava filters in pregnancy: a systematic review. J Vasc Interv Radiol. 2016;27(3):354–60.e8. doi:10.1016/j.jvir.2015.11.024
  • Pfeifer GW. Distribution and placental transfer of 131-I streptokinase. Australas Ann Med. 1970;19 Suppl 1:17–18. doi:10.1111/imj.1970.19.s1.17
  • Holden EL, Ranu H, Sheth A, Shannon MS, Madden BP. Thrombolysis for massive pulmonary embolism in pregnancy--a report of three cases and follow up over a two year period. Thromb Res. 2011;127(1):58–59. doi:10.1016/j.thromres.2010.06.003
  • te Raa GD, Ribbert LSM, Snijder RJ, Biesma DH. Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature. Thromb Res. 2009;124(1):1–5. doi:10.1016/j.thromres.2009.03.001
  • Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med. 2002;162(11):1221–1227. doi:10.1001/archinte.162.11.1221
  • Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92–128. doi:10.1007/s11239-015-1309-0
  • Dresang LT, Fontaine P, Leeman L, King VJ. Venous thromboembolism during pregnancy. Am Fam Physician. 2008;77(12):1709–1716.
  • Maughan BC, Marin M, Han J, et al. Venous thromboembolism during pregnancy and the postpartum period: risk factors, diagnostic testing, and treatment. Obstet Gynecol Surv. 2022;77(7):433–444. doi:10.1097/OGX.0000000000001043
  • Biron-Andreani C, Schved JF, Daures JP. Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis. Thromb Haemost. 2006;96(1):14–18. doi:10.1160/TH06-02-0086
  • Sultan AA, Tata LJ, West J, et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood. 2013;121(19):3953–3961. doi:10.1182/blood-2012-11-469551
  • Konstantinides V, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405
  • Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008;6(6):905–912. doi:10.1111/j.1538-7836.2008.02961.x
  • Kim YH, Pfaller B, Marson A, Yim HW, Huang V, Ito S. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: a systematic review and meta-analysis. Medicine. 2019;98(38):e17309. doi:10.1097/MD.0000000000017309
  • Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol. 2012;156(3):366–373. doi:10.1111/j.1365-2141.2011.08956.x
  • Clowse MEB, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1–6. doi:10.1016/j.ajog.2008.03.012
  • Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177. doi:10.1136/bmj.m2177
  • De Stefano V, Martinelli I, Rossi E, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006;135(3):386–391. doi:10.1111/j.1365-2141.2006.06317.x
  • Abe K, Kuklina EV, Hooper WC, Callaghan WM. Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Semin Perinatol. 2019;43(4):200–204. doi:10.1053/j.semperi.2019.03.004
  • Sare GM, Gray LJ, Bath PMW. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J. 2008;29(16):2031–2041. doi:10.1093/eurheartj/ehn299
  • Gomes V, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004;164(18):1965–1976. doi:10.1001/archinte.164.18.1965
  • Rogolino A, Coccia ME, Fedi S, et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2003;14(3):277–282. doi:10.1097/01.mbc.0000061296.28953.d0
  • Biron C, Galtier-Dereure F, Rabesandratana H, et al. Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study. Fertil Steril. 1997;67(1):104–109. doi:10.1016/s0015-0282(97)81864-x
  • Phillips LL, Gladstone W, Vande Wiele R. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J Reprod Med. 1975;14(4):138–143.
  • Bauersachs RM, Dudenhausen J, Faridi A, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost. 2007;98(6):1237–1245. doi:10.1160/th07-05-0329
  • Alijotas-Reig J, Ferrer-Oliveras R; EUROAPS Study Group. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report. Lupus. 2012;21(7):766–768. doi:10.1177/0961203312440058
  • Chan WS, Lee A, Spencer FA, et al. Predicting deep venous thrombosis in pregnancy: out in “LEFt” field? Ann Intern Med. 2009;151(2):85–92. doi:10.7326/0003-4819-151-2-200907210-00004
  • Varrias D, Sharma N, Hentz R, et al. Clinical significance of unexplained persistent sinus tachycardia in women with structurally normal heart during the peripartum period. BMC Pregnancy Childbirth. 2022;22(1):677. doi:10.1186/s12884-022-05012-3
  • Goodacre S, Horspool K, Nelson-Piercy C, et al. The DiPEP study: an observational study of the diagnostic accuracy of clinical assessment, D-dimer and chest x-ray for suspected pulmonary embolism in pregnancy and postpartum. BJOG. 2019;126(3):383–392. doi:10.1111/1471-0528.15286
  • Gregory E. Nursing practice management: Karen, aged 15 years, has an above-the-knee amputation. The Journal of School Nursing. 1992;8(1):30, 32.
  • McLintock C, Brighton T, Chunilal S, et al. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period. Aust N Z J Obstet Gynaecol. 2012;52(1):14–22. doi:10.1111/j.1479-828X.2011.01361.x
  • van der Pol LM, Tromeur C, Bistervels IM, et al. Pregnancy-adapted years algorithm for diagnosis of suspected pulmonary embolism. N Engl J Med. 2019;380(12):1139–1149. doi:10.1056/NEJMoa1813865
  • Fuller GW, Nelson-Piercy C, Hunt BJ, et al. Consensus-derived clinical decision rules to guide advanced imaging decisions for pulmonary embolism in pregnancy and the postpartum period. Eur J Emerg Med. 2018;25(3):221–222. doi:10.1097/MEJ.0000000000000477
  • Chan WS, Lee A, Spencer FA, et al. D-dimer testing in pregnant patients: towards determining the next “level” in diagnosing deep vein thrombosis. J Thromb Haemost. 2010;8(5):1004–1011. doi:10.1111/j.1538-7836.2010.03783.x
  • Phillips JJ, Straiton J, Staff RT. Planar and SPECT ventilation/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: a systematic review and meta-analysis of the literature, and cost and dose comparison. Eur J Radiol. 2015;84(7):1392–1400. doi:10.1016/j.ejrad.2015.03.013
  • Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A review: radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab. 2015;100(2):376–383. doi:10.1210/jc.2014-3292
  • ACOG Committee on Obstetric Practice. ACOG committee opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e210–e216. doi:10.1111/j.1479-828X.2011.01361.x
  • Astani SA, Davis LC, Harkness BA, Supanich MP, Dalal I. Detection of pulmonary embolism during pregnancy: comparing radiation doses of CTPA and pulmonary scintigraphy. Nucl Med Commun. 2014;35(7):704–711. doi:10.1097/MNM.0000000000000114
  • Perisinakis K, Seimenis I, Tzedakis A, Damilakis J. Perfusion scintigraphy versus 256-slice CT angiography in pregnant patients suspected of pulmonary embolism: comparison of radiation risks. J Nucl Med. 2014;55(8):1273–1280. doi:10.2967/jnumed.114.137968
  • Nguyen ET, Hague C, Manos D, et al. Canadian Society of Thoracic Radiology/Canadian association of radiologists best practice guidance for investigation of acute pulmonary embolism, part 1: acquisition and safety considerations. Can Assoc Radiol J. 2022;73(1):203–213. doi:10.1177/08465371211000737
  • Bellesini M, Robert-Ebadi H, Combescure C, Dedionigi C, Le Gal G, Righini M. D-dimer to rule out venous thromboembolism during pregnancy: a systematic review and meta-analysis. J Thromb Haemost. 2021;19(10):2454–2467. doi:10.1111/jth.15432
  • Bezemer ID, van der Meer FJM, Eikenboom JCJ, Rosendaal FR, Doggen CJM. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169(6):610–615. doi:10.1001/archinternmed.2008.589
  • Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009;113(21):5298–5303. doi:10.1182/blood-2008-11-190389
  • Spanos M, Gokulnath P, Chatterjee E, Guoping L, Varrias D, Saumya D. Expanding the horizon of EV-RNAs: lncRNAs in EVs as biomarkers for disease pathways. Extracell Vesicle. 2023;2:100025. doi:10.1016/j.vesic.2023.100025
  • Dahm AEA, Bezemer ID, Bergrem A, et al. Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis. Br J Haematol. 2012;157(6):753–761. doi:10.1111/j.1365-2141.2012.09121.x
  • Heyl PS, Sappenfield WM, Burch D, Hernandez LE, Kavanaugh VM, Hill WC. Pregnancy-related deaths due to pulmonary embolism: findings from two state-based mortality reviews. Matern Child Health J. 2013;17(7):1230–1235. doi:10.1007/s10995-012-1117-5
  • American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin No. 196: thromboembolism in pregnancy. Obstet Gynecol. 2018;132(1):e1–e17. doi:10.1097/AOG.0000000000002706
  • Le Roux PY, Pelletier-Galarneau M, De Laroche R, et al. Pulmonary scintigraphy for the diagnosis of acute pulmonary embolism: a survey of current practices in Australia, Canada, and France. J Nucl Med. 2015;56(8):1212–1217. doi:10.2967/jnumed.115.157743
  • Linnemann B, Bauersachs R, Rott H, et al. Diagnosis of pregnancy-associated venous thromboembolism - position paper of the working group in women’s health of the society of thrombosis and haemostasis (GTH). Vasa. 2016;45(2):87–101. doi:10.1024/0301-1526/a000503
  • Lieveld A, Heldeweg MLA, Smit JM, et al. Multi-organ point-of-care ultrasound for detection of pulmonary embolism in critically ill COVID-19 patients – a diagnostic accuracy study. J Crit Care. 2022;69:153992. doi:10.1016/j.jcrc.2022.153992
  • Barrosse-Antle ME, Patel KH, Kramer JA, Baston CM. Point-of-care ultrasound for bedside diagnosis of lower extremity DVT. Chest. 2021;160(5):1853–1863. doi:10.1016/j.chest.2021.07.010
  • Varrias D, Palaiodimos L, Balasubramanian P, et al. The use of point-of-care ultrasound (POCUS) in the diagnosis of deep vein thrombosis. J Clin Med. 2021;10:3903. doi:10.3390/jcm10173903
  • Chan WS, Spencer FA, Lee AY, et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ. 2013;185(4):E194–200. PMID: 23318405; PMCID: PMC3589327. doi:10.1503/cmaj.120895
  • Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830. doi:10.1161/CIR.0b013e318214914f
  • Kalaitzopoulos DR, Panagopoulos A, Samant S, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106–113. doi:10.1016/j.thromres.2022.02.002
  • Sousa Gomes M, Guimarães M, Montenegro N. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med. 2019;32(14):2418–2428. doi:10.1080/14767058.2018.1434141
  • Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J. 2005;26(5):864–874. doi:10.1183/09031936.05.00002505
  • Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605–614. doi:10.1093/eurheartj/ehu218
  • Martillotti G, Boehlen F, Robert-Ebadi H, Jastrow N, Righini M, Blondon M. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost. 2017;15(10):1942–1950. doi:10.1111/jth.13802
  • Monteleone PP, Rosenfield K, Rosovsky RP. Multidisciplinary pulmonary embolism response teams and systems. Cardiovasc Diagn Ther. 2016;6(6):662–667. doi:10.21037/cdt.2016.11.05
  • Samuelson Bannow B, Federspiel JJ, Abel DE, Mauney L, Rosovsky RP, Bates SM. Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the foundation for women and girls with blood disorders thrombosis subcommittee. J Thromb Haemost. 2023. doi:10.1016/j.jtha.2023.03.015